Compare Brigit Biofarmaka Teknologi Tbk. (OBAT) vs Suparma Tbk. (SPMA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Brigit Biofarmaka Teknologi Tbk. vs Suparma Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 164.65B, 49.4K 24h volume), while Suparma Tbk. trades at Rp164 (market cap 874.19B, 708.6K 24h volume). The key difference: Suparma Tbk. is far larger — about 5.3× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Suparma Tbk. is more actively traded (708.6K versus 49.4K). Which is the better fit depends on your goals.
| OBAT | SPMA | |
|---|---|---|
Market Cap | 164.65B | 874.19B |
Volume | 49.4K | 708.6K |
Lot | 494 | 7.09K |
Turnover | 11.92M | 118.9M |
Average Price | 241.24 | 167.79 |
Value | 11.92M | 118.9M |
Indicative Equilibrium Price | 238 | — |
Indicative Equilibrium Volume | 100 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →About Suparma Tbk.
PT Suparma Tbk (Entity) was established under the Domestic Capital Investment Law No. 6 of 1968 as amended by Law No. 12 of 1970 based on the Notarial Deed No. 29 of Tjahjadi Hartanto, S.H., on August 25, 1976. The Entity's name, PT Supar Inpama was changed to PT Suparma based in the Notarial Deed No. 5 dated December 7, 1978 of the same notary.
Read more on SPMA →
